Top Chicago, IL Health Tech Companies With Best Stability & Growth (359)
.png)
Artera, a SaaS leader in digital health, transforms patient experience with AI-powered virtual agents (voice and text) for every step of the patient journey. Trusted by 1,000+ provider organizations — including specialty groups, FQHCs, large IDNs and federal agencies — engaging 100 million patients annually. Artera’s virtual agents support front desk staff to improve patient access including self-scheduling, intake, forms,...
Artera's Top Stability & Growth Strengths
Strong Revenue Growth: Recent announcements cite reaching $100M in contracted annual recurring revenue by the end of 2025. Deloitte’s 2025 Technology Fast 500 placement with high multi‑year growth reinforces momentum.
Investor Backing & Capital Strength: A $65M growth investment announced in December 2025, following earlier rounds, provides capital to accelerate expansion. Company statements link the funding to scaling adoption of AI agents in healthcare.
Strong Market Position & Advantage: Multiple recognitions (e.g., Deloitte Fast 500, Best in KLAS for Patient Communications) and claims of 1,000+ healthcare organizations and federal agencies using the platform point to durable market traction. Reported billions of annual patient‑provider communications further illustrate operating scale.
We bring together one of the world’s largest libraries of multimodal clinical and molecular data with a robust suite of AI tools to help physicians personalize care in real time, connect patients with therapies and clinical trials, and enable partners to accelerate discovery and development of new treatments. With ~8 million de-identified research records and 350+ petabytes of data, Tempus partners...
Tempus AI's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results and guidance show steep top-line expansion, with Q1 2026 revenue up year over year and full‑year 2026 outlook raised, indicating continued momentum.
Strategic Partnerships: Collaborations with major pharmaceutical companies and tools providers (e.g., AstraZeneca/Pathos, Merck, Gilead, Illumina, BMS) broaden product reach and support sustained demand.
Diversified Revenue Streams: Growth across Diagnostics and higher‑margin Data & Applications, alongside expanding offerings such as digital pathology and care pathway tools, indicates multiple engines contributing to scale.
At PatientPoint, we're transforming every doctor-patient interaction with cutting-edge, technology-driven solutions designed to improve health outcomes and quality of life. By delivering impactful, digital, in-office patient education at no cost to physicians across the country, we empower healthcare professionals to connect more meaningfully with their patients. Through partnerships with trusted healthcare brands like Pfizer, P&G, Sanofi, Merck, NatureMade, and Bristol...
PatientPoint's Top Stability & Growth Strengths
Strong Market Position & Advantage: Press and company materials describe PatientPoint as operating the largest U.S. digital point‑of‑care network (roughly 30,000 offices and 125,000 providers), reinforced by expanded MRC accreditation across its national screens in 2026. These signals support durable reach and verified delivery attractive to advertisers.
Product Line Growth: In March 2026, the company launched Health Audiences, adding programmatic buying access to point‑of‑care inventory aligned with the industry’s shift to data‑driven digital spend. This complements prior specialty additions and strengthens monetization options at the point of care.
Investor Backing & Capital Strength: In August 2025, Advent International signed a definitive agreement to acquire PatientPoint with the stated goal of accelerating network growth and product innovation. This sponsor commitment indicates access to capital and support for continued expansion.
We are a purpose driven healthcare technology company passionate about innovation and using technology to help people by solving real world problems. The ALIS team designs, builds, delivers, and supports our flagship product ALIS (pronounced “Alice” and stands for Assisted Living Integrated Solution).
ALIS's Top Stability & Growth Strengths
Product Line Growth: Recent launches such as ALIS 500 benchmarking, the ALIS 500 Clinical Report, Ask ALIS (AI assistant), and ALIS HQ indicate active expansion of offerings. Release notes through 2025–2026 and new modules reflect a sustained shipping cadence.
Innovation-Driven Growth: AI and data initiatives (e.g., Ask ALIS and benchmarking built from hundreds of communities’ data) show investment in differentiated capabilities. Partners initially launching new workflows with ALIS further signal innovation pull.
Strategic Partnerships: Announced integrations with CarePredict and other ecosystem vendors, NIC MAP Vision certification, and an open‑API/app‑store approach point to a growing partner network. Support materials cite additional integrations consistent with deeper enterprise adoption.
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000+ employees in over 40 offices worldwide.
ZS's Top Stability & Growth Strengths
Strong Hiring & Retention: Headcount moved from a verified 12,743 employees at year‑end 2024 to the firm’s current “15,000+” positioning in 2026, and 2024 saw notable promotions—signaling sustained hiring and talent progression.
Market Expansion: The company cites “40+” offices and completed a new Chicago office build in 2025, indicating continued geographic and physical footprint growth through 2025–2026.
Innovation-Driven Growth: Creation of a dedicated Platforms & Products unit and ongoing investment in ZAIDYN and AI, alongside capability‑accretive M&A such as Torrent Consulting, suggest an innovation‑led scaling strategy.
Prolaio is a clinical intelligence company dedicated to unlocking continuous, predictive and shareable heart data to liberate patients from hospital-based reactive care and accelerate every new therapy. The company was created by cardiologists, cardiovascular practitioners, and data scientists specifically to address the world’s number one cause of death — cardiovascular disease. By combining scientific rigor with cutting‑edge technology, Prolaio aims...
Prolaio's Top Stability & Growth Strengths
Strategic Partnerships: Kardigan’s March 2025 acquisition of Prolaio, alongside statements that Prolaio will continue operating independently while leveraging Kardigan’s scale, signals added resources and distribution for scale‑up. Feedback suggests this combination is intended to extend the platform’s reach across researchers, providers, and biopharma.
Market Expansion: Public materials cite operations in 26+ countries and active, post‑acquisition hiring and role postings, indicating geographic and organizational expansion. The nationwide, all‑remote OCORO Heart Study further reflects expanding field activity and data generation.
Innovation-Driven Growth: Regulatory milestones—including multiple FDA‑cleared algorithms and the December 2025 eVO2peak clearance—indicate a maturing product and evidence base. Company‑reported millions of patient‑hours and ongoing study activity suggest continued product and research execution.
Kalderos is a data infrastructure and analytics company that’s solving challenges around drug discounts in the U.S. healthcare system. Through platform technology and big data, our team is delivering smart solutions that enable healthcare stakeholders to collaborate with greater transparency and trust. We’re passionate about our mission to take on the most stubborn challenges in healthcare. We also know that...
Kalderos's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Recent funding trackers indicate a fresh 2025 round of about $26.35M, bringing total capital raised to roughly $76M—providing fuel to scale product and go‑to‑market.
Market Expansion: Multiple 2025–2026 manufacturer and distributor notices show transitions to Truzo (e.g., Alkermes, Organon, Gilead via Cencora). These migrations suggest growing adoption across stakeholders.
Product Line Growth: Kalderos promotes Truzo as an end‑to‑end drug discount management platform and continues to enhance solutions like Discount Hub and Commercial Discount Monitoring. Industry commentary and company materials highlight expanding capabilities aligned to today’s 340B environment.
.png){kind=logo}
Here at Strata, we provide financial planning software, data, and insights to drive decisions and performance for organizations spanning the healthcare, higher education, and financial services industries.
Strata Decision Technology's Top Stability & Growth Strengths
Market Expansion: The combination with Syntellis broadened Strata’s reach beyond healthcare into higher education and financial institutions while retaining the Strata name and leadership. The stated customer footprint of more than 2,300 organizations reflects the expanded scope of the combined platform.
Product Line Growth: The March 31, 2026 launch of an AI-driven Predictive Analytics solution for healthcare finance forecasting indicates active R&D and continued portfolio expansion. Ongoing solution enhancements suggest a cadence of product investment aligned to customer needs.
Strong Market Position & Advantage: Sustained No. 1 placement in KLAS for business decision support and a large installed base reinforce defensibility in core segments. Parent-company support and high recurring software revenue characteristics further underpin competitive positioning.
PUSH is the first fair and effective progress-based health and wellness incentive program. The program leverages principles of behavioral economics to effect health behavior change, producing tangible benefits for organizations and their valued employees. This unique incentive management concept was developed by Dr. Greg Vachon, a practicing internist with over 25 years of experience in clinical practice and behavioral health...
Northwestern Medicine is the collaboration between Northwestern Memorial HealthCare and Northwestern University Feinberg School of Medicine around a strategic vision to transform the future of healthcare. It encompasses the research, teaching, and patient care activities of the academic medical center.
Northwestern Medicine's Top Stability & Growth Strengths
Strong Market Position & Advantage: Evidence indicates Northwestern Medicine, anchored by Northwestern Memorial Hospital, holds sustained top placement in Illinois and national Honor Roll recognition, signaling durable competitive advantage in a highly competitive Chicago market. Feedback suggests additional third-party quality and safety accolades (e.g., Vizient Top Performer, Leapfrog A grades, Newsweek listings) reinforce brand strength across complex care.
Market Expansion: Evidence indicates the system is adding capacity across inpatient, ICU, and surgical platforms (Lake Forest pavilions, NMH ICU expansion approval, proposed new ORs, and a large inpatient tower under review), alongside new and expanded outpatient sites. Feedback suggests these projects broaden regional access and position advanced programs closer to patients across 11 hospitals and 200+ sites.
Strong Revenue Growth: Evidence indicates operating revenue grew year over year and recent patient-service revenue increased meaningfully in the latest six-month period. Feedback suggests top-line momentum is aligned with higher volumes and service-line investments even as the cost environment remains challenging.
Point C is a National Third-Party Administrator (TPA) with local market presence that delivers customized self-funded benefit programs. Our commitment and partnership means thinking beyond the typical solutions in the market – to do more for your clients – and take you beyond the standard “Point A to Point B.” Our TPA partners have decades of experience curating custom healthcare plans...
.png)
The American Medical Association is the premier national organization providing timely, essential resources to empower physicians, residents and medical students to succeed at every phase of their medical lives. Physicians have entrusted the AMA to advance the art and science of medicine and the betterment of public health on behalf of patients for more than 170 years.
.png)
BiomeSense is developing an integrated biosensor and bioinformatics platform to enable time-series collection and analysis of human gut microbiome data during clinical research. Our technology provides exponentially more data to scientists than current tools, dramatically accelerating clinical translation of microbiome research.
Healthcare is changing. Healthcare organizations are growing. Care continues to expand outside of the hospital walls. This provides more capacity to utilize scale to create healthcare companies that are better functioning, smarter organizations. Intra-company logistics - the enterprise-wide movement of physical materials, such as blood and specimens, pharmaceuticals and supplies - is the foundation of the healthcare supply chain. Healthcare...
Avalign Technologies is a premier, full-service supplier of surgical implants, instruments, and delivery systems. Avalign is one of the fastest growing companies serving the high tech, high growth medical device industry. We are an ambitious company with significant financial backing, a strong track record of success, and big plans for the future. These plans start with attracting, developing, retaining, and...
Stridekick is a social fitness platform that integrates with the leading fitness trackers and smartwatches to allow individuals to participate in fun fitness challenges with friends, family and coworkers. For larger groups and organizations, check out our flexible enterprise platform, MoveSpring.
Sia Partners is a next generation management consulting firm and pioneer of Consulting 4.0. We offer a unique blend of AI and design capabilities, augmenting traditional consulting to deliver superior value to our clients. Counting 1,800 consultants in 18 countries, we expect to achieve USD 300 million in turnover for the current fiscal year. With a global footprint and expertise...
Sia Partners's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Recent investment by Blackstone of up to €250 million in December 2024 provides growth capital and signals external confidence in the firm’s expansion plans. Company statements link this funding to accelerating U.S. growth, M&A, and AI-enabled offerings.
Market Expansion: Multiple acquisitions and a sustained U.S. push (e.g., Notion Consulting, Ready Set Rocket, Precedence, Kaiser Associates) indicate ongoing geographic and service-line expansion across North America and Europe. Leadership attention to the U.S. market and a growing office footprint suggest increased depth in key geographies.
Innovation-Driven Growth: The firm is productizing AI (e.g., SiaGPT and 800+ deployable AI agents by April 2026) and launching new lines like Corporate Strategy, PE & M&A, pointing to growth via differentiated, tech-enabled delivery. Partnerships and ecosystem recognition around NVIDIA and AWS reinforce momentum in AI-driven consulting.
Interactive Health (www.interactivehealthinc.com), the country’s leading provider of health management solutions, creates innovative wellness programs designed to increase overall company health and actively engage employees to make lasting behavior changes.
Our enterprise performance management software, data and analytics solutions help finance professionals in healthcare, higher education and financial institutions elevate performance by acquiring insights, accelerating decisions, and advancing their business plans. With over 2,800 organizations and 450,000 users relying on our solutions, we have proven industry expertise in helping organizations transform their vision into reality. We help hospitals deliver the...
Jellyvision is on a mission to improve lives by helping people choose and use their benefits. You will contribute to meaningful, empowering work that enables us to continue to raise the bar for the healthcare and benefits experience. You will live and breathe “be helpful.” Jellyvision people are creative problem solvers. Respect and trust are at our core, which means we...
Jellyvision's Top Stability & Growth Strengths
Strong Market Position & Advantage: Evidence indicates Jellyvision/ALEX is a long‑standing, widely recognized participant in benefits decision support, frequently cited among the primary vendors and deployed by 1,500+ employers with broad employee reach. Practitioner visibility and repeated inclusion in market overviews reinforce durable category presence rather than a niche outlier.
Product Line Growth: Recent launches such as ALEX Home (year‑round benefits help) and Leave Management powered by Aidora, alongside the Picwell acquisition for AI‑driven recommendations, expand the platform beyond open enrollment into ongoing workflows. This broadening of capabilities signals active investment and a widening total addressable use case.
Strategic Partnerships: Integrations and co‑go‑to‑market motions with ecosystem players (e.g., Conduent Life@Work Connect) suggest strengthened distribution and embedment within benefits administration platforms. Public materials highlight multiple partnerships that extend reach and stickiness in employer tech stacks.
